BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lumachi F, Santeufemia DA, Basso SM. Current medical treatment of estrogen receptor-positive breast cancer. World J Biol Chem 2015; 6(3): 231-239 [PMID: 26322178 DOI: 10.4331/wjbc.v6.i3.231]
URL: https://www.wjgnet.com/1948-9358/full/v6/i3/231.htm
Number Citing Articles
1
Ya-Chi Chen, Jiajie Yu, Ciara Metcalfe, Tom De Bruyn, Thomas Gelzleichter, Vikram Malhi, Pablo D. Perez-Moreno, Xiaojing Wang. Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancerExpert Opinion on Investigational Drugs 2022; 31(6): 515 doi: 10.1080/13543784.2021.1983542
2
Engin Kut, Serkan Menekse. Retrospective Evaluation of Fulvestrant Efficacy and Clinical Results in Patients Using FulvestrantCureus 2023;  doi: 10.7759/cureus.35748
3
G S Hwang, R Bhat, R D Crutchley, M V Trivedi. Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomesThe Pharmacogenomics Journal 2018; 18(2): 201 doi: 10.1038/tpj.2017.36
4
Wabel AL-Busairi, Maitham Khajah. Tumor Progression and Metastasis2020;  doi: 10.5772/intechopen.86729
5
Nusrat Jan, Shazia Sofi, Hina Qayoom, Burhan Ul Haq, Aisha Shabir, Manzoor Ahmad Mir. Targeting breast cancer stem cells through retinoids: A new hope for treatmentCritical Reviews in Oncology/Hematology 2023; 192: 104156 doi: 10.1016/j.critrevonc.2023.104156
6
Aimee A. D’Aloisio, Hazel B. Nichols, M. Elizabeth Hodgson, Sandra L. Deming-Halverson, Dale P. Sandler. Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancerBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3686-6
7
Margaret A. Zimmerman, Rebecca A. Budish, Shreya Kashyap, Sarah H. Lindsey. GPER–novel membrane oestrogen receptorClinical Science 2016; 130(12): 1005 doi: 10.1042/CS20160114
8
Yuanqin Zhang, Xiangwei Fang, Jiuhui Wang, Daotai Nie. TMEM97/Sigma 2 Receptor Increases Estrogen Receptor α Activity in Promoting Breast Cancer Cell GrowthCancers 2023; 15(23): 5691 doi: 10.3390/cancers15235691
9
Carlos Martínez-Campa, Javier Menéndez-Menéndez, Carolina Alonso-González, Alicia González, Virginia Álvarez-García, Samuel Cos. What is known about melatonin, chemotherapy and altered gene expression in breast cancerOncology Letters 2017; 13(4): 2003 doi: 10.3892/ol.2017.5712
10
Jie Xu, Cheol K. Chung, Andrew McClory, Kyle A. Mack, Michael E. Dalziel, Alec Fettes, Kyle Clagg, Ngiap-Kie Lim, Georg Wuitschik, Christian Jenny, Laure Finet, Michael Kammerer, Haiming Zhang, Rémy Angelaud, Francis Gosselin. Efficient Manufacturing Process for the Selective Estrogen Receptor Degrader GDC-9545 (Giredestrant) via a Crystallization-Driven Diastereoselective Pictet–Spengler CondensationOrganic Process Research & Development 2022; 26(3): 568 doi: 10.1021/acs.oprd.1c00263
11
Farzin Khosrow-Khavar, Nathaniel Bouganim, Kristian B Filion, Samy Suissa, Laurent Azoulay. Cardiotoxicity of Use of Sequential Aromatase Inhibitors in Women With Breast CancerAmerican Journal of Epidemiology 2020; 189(10): 1086 doi: 10.1093/aje/kwaa065
12
Joshua P. Dignam, Smriti Sharma, Ioannis Stasinopoulos, Margaret R. MacLean. Pulmonary arterial hypertension: Sex mattersBritish Journal of Pharmacology 2024; 181(7): 938 doi: 10.1111/bph.16277
13
Antonella Ferro, Daniele Generali, Orazio Caffo, Alessia Caldara, Delia De Lisi, Mariachiara Dipasquale, Martina Lorenzi, Sara Monteverdi, Palma Fedele, Yari Ciribilli. Oral selective estrogen receptor degraders (SERDs): The new emperors in breast cancer clinical practice?Seminars in Oncology 2023; 50(3-5): 90 doi: 10.1053/j.seminoncol.2023.08.002
14
Keli He, Li Zhang, Xinghua Long. Quantitative assessment of the association between APC promoter methylation and breast cancerOncotarget 2016; 7(25): 37920 doi: 10.18632/oncotarget.9354
15
Yury V. Kuznetsov, Inna S. Levina, Alexander M. Scherbakov, Olga E. Andreeva, Irina V. Fedyushkina, Andrey S. Dmitrenok, Alexander S. Shashkov, Igor V. Zavarzin. New estrogen receptor antagonists. 3,20-Dihydroxy-19-norpregna-1,3,5(10)-trienes: Synthesis, molecular modeling, and biological evaluationEuropean Journal of Medicinal Chemistry 2018; 143: 670 doi: 10.1016/j.ejmech.2017.11.042
16
Amelie Heesch, Jochen Maurer, Elmar Stickeler, Mohsen Beheshti, Felix M. Mottaghy, Agnieszka Morgenroth. Development of Radiotracers for Breast Cancer—The Tumor Microenvironment as an Emerging TargetCells 2020; 9(10): 2334 doi: 10.3390/cells9102334
17
Huseyin Beyaz, Hasan Uludag, Doga Kavaz, Nahit Rizaner. Cell Biology and Translational Medicine, Volume 14Advances in Experimental Medicine and Biology 2021; 1347: 163 doi: 10.1007/5584_2021_648
18
Lauren D. Otto, Kathryn L. G. Russart, Praveen Kulkarni, Dana M. McTigue, Craig F. Ferris, Leah M. Pyter. Paclitaxel Chemotherapy Elicits Widespread Brain Anisotropy Changes in a Comprehensive Mouse Model of Breast Cancer Survivorship: Evidence From In Vivo Diffusion Weighted ImagingFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.798704
19
Nicolas Carels, Lizânia Borges Spinassé, Tatiana Martins Tilli, Jack Adam Tuszynski. Toward precision medicine of breast cancerTheoretical Biology and Medical Modelling 2016; 13(1) doi: 10.1186/s12976-016-0035-4
20
Chun-Yu Liu, Chia-Yun Wu, Karineh Petrossian, Tzu-Ting Huang, Ling-Ming Tseng, Shiuan Chen. Treatment for the endocrine resistant breast cancer: Current options and future perspectivesThe Journal of Steroid Biochemistry and Molecular Biology 2017; 172: 166 doi: 10.1016/j.jsbmb.2017.07.001
21
Alexandru Filippi, Maria-Magdalena Mocanu. Mining TCGA Database for Genes with Prognostic Value in Breast CancerInternational Journal of Molecular Sciences 2023; 24(2): 1622 doi: 10.3390/ijms24021622
22
F. Khosrow-Khavar, H. Yin, A. Barkun, N. Bouganim, L. Azoulay. Aromatase inhibitors and the risk of colorectal cancer in postmenopausal women with breast cancerAnnals of Oncology 2018; 29(3): 744 doi: 10.1093/annonc/mdx822
23
Hala Attia, Afraa Alzoubi, Nour Al-anazi, Aliah Alshanwani, Naglaa El-Orabi, Alaa Alanteet, Raeesa Mohamad, Rehab Ali. Protective effects of cardamom aqueous extract against tamoxifen-induced pancreatic injury in female ratsToxicological Research 2023; 39(4): 721 doi: 10.1007/s43188-023-00198-w
24
Yu Zhong Peng, Li Jun Yang, Hang Hong Lo, Betty Yuen Kwan Law, Vincent Kam Wai Wong. New Nanomaterials and Techniques for Tumor-targeted Systems2020; : 135 doi: 10.1007/978-981-15-5159-8_6
25
Yu. V. Kuznetsov, I. S. Levina, A. S. Shashkov, I. V. Zavarzin. An efficient synthesis of 3-methoxy-19-norpregna-1,3,5(10),16-tetraen-20-oneRussian Chemical Bulletin 2018; 67(11): 2112 doi: 10.1007/s11172-018-2337-7
26
Vera Sorin, Eyal Klang, Miri Sklair-Levy, Israel Cohen, Douglas B. Zippel, Nora Balint Lahat, Eli Konen, Yiftach Barash. Large language model (ChatGPT) as a support tool for breast tumor boardnpj Breast Cancer 2023; 9(1) doi: 10.1038/s41523-023-00557-8
27
Nora Jung, Veronique Maguer-Satta, Boris Guyot. Early Steps of Mammary Stem Cell Transformation by Exogenous Signals; Effects of Bisphenol Endocrine Disrupting Chemicals and Bone Morphogenetic ProteinsCancers 2019; 11(9): 1351 doi: 10.3390/cancers11091351
28
Lokman Varisli, Garrett M. Dancik, Veysel Tolan, Spiros Vlahopoulos. Critical Roles of SRC-3 in the Development and Progression of Breast Cancer, Rendering It a Prospective Clinical TargetCancers 2023; 15(21): 5242 doi: 10.3390/cancers15215242
29
Michael K. McGrath, Ali Abolhassani, Luke Guy, Ahmed M. Elshazly, John T. Barrett, Nahid F. Mivechi, David A. Gewirtz, Patricia V. Schoenlein. Autophagy and senescence facilitate the development of antiestrogen resistance in ER positive breast cancerFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1298423
30
Lindsay E. Calderon, Jonathan K. Keeling, Joseph Rollins, Carrie A. Black, Kendall Collins, Nova Arnold, Diane E. Vance, Margaret W. Ndinguri. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH ReceptorBioconjugate Chemistry 2017; 28(2): 461 doi: 10.1021/acs.bioconjchem.6b00610
31
Çağla KAYABAŞI, Çığır Biray AVCI, Sunde YILMAZ SÜSLÜER, Tuğçe BALCI OKCANOĞLU, Besra ÖZMEN YELKEN, Cansu ÇALIŞKAN KURT, Bakiye GÖKER BAĞCA, Cenk DURMUŞKAHYA, Hüsniye KAYALAR, Ahmet ÖZBİLGİN, Cumhur GÜNDÜZ. Ponatinib ve Türkiye’de yetişen bazı endemik bitki ekstrelerinin kombinasyonlarının meme kanseri hücreleri üzerindeki etkileriEge Tıp Dergisi 2022; 61(2): 232 doi: 10.19161/etd.1126901
32
Masriana Vivi Simanjuntak, Muhammad Miftah Jauhar, Putri Hawa Syaifie, Adzani Gaisani Arda, Etik Mardliyati, Wervyan Shalannanda, Beni Rio Hermanto, Isa Anshori. Revealing Propolis Potential Activity on Inhibiting Estrogen Receptor and Heat Shock Protein 90 Overexpressed in Breast Cancer by Bioinformatics ApproachesBioinformatics and Biology Insights 2024; 18 doi: 10.1177/11779322231224187
33
Debbie Yancu, Rachel Viau, Thomas Sanderson. Development of an estrogen-dependent breast cancer co-culture model as a tool for studying endocrine disruptorsToxicology in Vitro 2020; 62: 104658 doi: 10.1016/j.tiv.2019.104658
34
Hoon Kim, Wonshik Han, Seung-Yup Ku, Chang Suk Suh, Seok Hyun Kim, Young Min Choi. Feature of amenorrhea in postoperative tamoxifen users with breast cancerJournal of Gynecologic Oncology 2017; 28(2) doi: 10.3802/jgo.2017.28.e10
35
Jie-Ning Li, Ming-Yang Wang, Yi-Ting Chen, Yao-Lung Kuo, Pai-Sheng Chen. Expression of SnoRNA U50A Is Associated with Better Prognosis and Prolonged Mitosis in Breast CancerCancers 2021; 13(24): 6304 doi: 10.3390/cancers13246304
36
Imane Ait Oumghar, Abdelwahed Barkaoui, Patrick Chabrand, Abdellatif El Ghazi, Charlotte Jeanneau, Daphne Guenoun, Peter Pivonka. Experimental-based mechanobiological modeling of the anabolic and catabolic effects of breast cancer on bone remodelingBiomechanics and Modeling in Mechanobiology 2022; 21(6): 1841 doi: 10.1007/s10237-022-01623-z
37
Brittany L. Witt, Trygve O. Tollefsbol. Molecular, Cellular, and Technical Aspects of Breast Cancer Cell Lines as a Foundational Tool in Cancer ResearchLife 2023; 13(12): 2311 doi: 10.3390/life13122311
38
Isabel Mayayo-Peralta, Beatrice Faggion, Liesbeth Hoekman, Ben Morris, Cor Lieftink, Isabella Goldsbrough, Lakjaya Buluwela, Joseph C. Siefert, Harm Post, Maarten Altelaar, Roderick Beijersbergen, Simak Ali, Wilbert Zwart, Stefan Prekovic. Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast CancerCancers 2021; 13(24): 6314 doi: 10.3390/cancers13246314
39
Pegah Shakeri, S. Mohsen Asghari, Esmaeel Panahi Kokhdan, Vaezeh Fathi Vavsari, Farhad Golmohammadi, Alireza Ghassempour, Saeed Balalaie. Synthesis, molecular modeling and functional evaluation of a GnRH antagonistJournal of the Iranian Chemical Society 2022; 19(7): 2705 doi: 10.1007/s13738-021-02484-6
40
Siew-Woh Choo, Yu Zhong, Edward Sendler, Anton-Scott Goustin, Juan Cai, Donghong Ju, Mary Ann Kosir, Roberta Giordo, Leonard Lipovich. Estrogen distinctly regulates transcription and translation of lncRNAs and pseudogenes in breast cancer cellsGenomics 2022; 114(4): 110421 doi: 10.1016/j.ygeno.2022.110421
41
Sara A Hurvitz, Aditya Bardia, Vanesa Quiroga, Yeon Hee Park, Isabel Blancas, José Luis Alonso-Romero, Aleksandr Vasiliev, Hryhoriy Adamchuk, Marcelo Salgado, Denise A Yardley, Oleksandr Berzoy, Pilar Zamora-Auñón, David Chan, Gonzalo Spera, Cloris Xue, Erika Ferreira, Tanja Badovinac Crnjevic, Pablo Diego Pérez-Moreno, Vanesa López-Valverde, Jutta Steinseifer, Tharu M Fernando, Heather M Moore, Peter A Fasching. Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 studyThe Lancet Oncology 2023; 24(9): 1029 doi: 10.1016/S1470-2045(23)00268-1
42
Yury V. Kuznetsov, Inna S. Levina, Alexander M. Scherbakov, Olga E. Andreeva, Andrey S. Dmitrenok, Oleg R. Malyshev, Igor V. Zavarzin. 3,20-Dihydroxy-13α-19-norpregna-1,3,5(10)-trienes. Synthesis, structures, and cytotoxic, estrogenic, and antiestrogenic effectsSteroids 2018; 137: 1 doi: 10.1016/j.steroids.2018.07.007
43
Tarek M. A. Abdel-Fatah, Graham R. Ball, Pulari U. Thangavelu, Lynne E. Reid, Amy E. McCart Reed, Jodi M. Saunus, Pascal H. G. Duijf, Peter T. Simpson, Sunil R. Lakhani, Lorinc Pongor, Balázs Gyorffy, Paul M. Moseley, Andrew R. Green, Alan G. Pockley, Carlos Caldas, Ian O. Ellis, Stephen Y. T. Chan. Association of Sperm-Associated Antigen 5 and Treatment Response in Patients With Estrogen Receptor–Positive Breast CancerJAMA Network Open 2020; 3(7): e209486 doi: 10.1001/jamanetworkopen.2020.9486
44
Carmen Ortiz-Sánchez, Jarline Encarnación-Medina, Ralphdy Vergne, Luis Padilla, Jaime Matta. Circulating Vitamin D Levels and DNA Repair Capacity in Four Molecular Subtypes of Women with Breast CancerInternational Journal of Molecular Sciences 2020; 21(18): 6880 doi: 10.3390/ijms21186880
45
Ruqaiyyah Siddiqui, Zinb Makhlouf, Ahmad M. Alharbi, Hasan Alfahemi, Naveed Ahmed Khan. The Gut Microbiome and Female HealthBiology 2022; 11(11): 1683 doi: 10.3390/biology11111683
46
Nikola Tanić, Tatjana Dramićanin, Nejla Ademović, Tijana Tomić, Blagoje Murganić, Zorka Milovanović, Milica Nedeljković, Nasta Tanić. The impact of TP53 and PTEN tumor suppressor genes on response to different breast cancer treatment modalitiesБиомедицинска истраживања 2022; 13(2): 105 doi: 10.5937/BII2202105T
47
Anna Rose McGrorry, Amy Paterson, Nicola Peddie. The effects of exercise on sleep disturbances and cancer‐related fatigue for female breast cancer survivors receiving adjuvant hormone therapy: A systematic reviewLifestyle Medicine 2023; 4(4) doi: 10.1002/lim2.92
48
Majed Shtaiwi, Mohammad Alemleh, Kayed A. Abu-Safieh, Bader A. Salameh, Amneh Shtaiwi, Mohammad Alwahsh, Lama Hamadneh, Monther A. Khanfar. Design, Synthesis, Crystal Structure, Biological Activity and Molecular Modeling of Novel Schiff Bases Derived from Chalcones and 5-Hydrazino-1,3-Dimethyl-4-Nitropyrazole as Anticancer AgentsPolycyclic Aromatic Compounds 2023; : 1 doi: 10.1080/10406638.2023.2247118
49
Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, Valéria Pereira Ferrer. Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast cancer and glioblastoma viewCytokine 2023; 170: 156344 doi: 10.1016/j.cyto.2023.156344
50
Rumeysa Ozyurt, Bulent Ozpolat. Molecular Mechanisms of Anti-Estrogen Therapy Resistance and Novel Targeted TherapiesCancers 2022; 14(21): 5206 doi: 10.3390/cancers14215206
51
Johannes Breyer, Ralph Markus Wirtz, Wolfgang Otto, Mark Laible, Kornelia Schlombs, Philipp Erben, Maximilian Christian Kriegmair, Robert Stoehr, Sebastian Eidt, Stefan Denzinger, Maximilian Burger, Arndt Hartmann. Predictive value of molecular subtyping in NMIBC by RT-qPCR of ERBB2, ESR1, PGR and MKI67 from formalin fixed TUR biopsiesOncotarget 2017; 8(40): 67684 doi: 10.18632/oncotarget.18804
52
Nadia Melillo, Francesco Paolo Cantatore. Breast cancer anti-hormonal therapy and rheumatic diseases: linking the clinical to molecular worldBeyond Rheumatology 2020; 2(1): 14 doi: 10.4081/br.2020.30
53
Yongmei Wang, Fanbo Jing, Haibo Wang. Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent EvidenceAdvances in Therapy 2022; 39(2): 862 doi: 10.1007/s12325-021-01924-2
54
Juan P. Muñoz, Gloria M. Calaf. Acetylcholine, Another Factor in Breast CancerBiology 2023; 12(11): 1418 doi: 10.3390/biology12111418
55
Sneha Pandithar, Daniel Galke, Ahone Akume, Artem Belyakov, Dominick Lomonaco, Amirah A. Guerra, Jay Park, Olivia Reff, Kideok Jin. The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblastMolecular Biology Reports 2024; 51(1) doi: 10.1007/s11033-023-09119-4
56
Salvador Flores-Torres, Tao Jiang, Jacqueline Kort-Mascort, Yun Yang, Omar Peza-Chavez, Sanjima Pal, Alisia Mainolfi, Lucas Antonio Pardo, Lorenzo Ferri, Nicholas Bertos, Veena Sangwan, Joseph M. Kinsella. Constructing 3D In Vitro Models of Heterocellular Solid Tumors and Stromal Tissues Using Extrusion-Based BioprintingACS Biomaterials Science & Engineering 2023; 9(2): 542 doi: 10.1021/acsbiomaterials.2c00998
57
Virginia G. Kaklamani, William J. Gradishar. Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast CancerThe Oncologist 2017; 22(5): 507 doi: 10.1634/theoncologist.2015-0464
58
Maria ACSM Borba, Renato P Melo-Neto, Glauber M Leitão, Carlos HM Castelletti, José L Lima-Filho, Danyelly BG Martins. Evaluating the impact of missenses mutations in CYP2D6*7 and CYP2D6*14A: does it compromise tamoxifen metabolism?Pharmacogenomics 2016; 17(6): 561 doi: 10.2217/pgs-2015-0003
59
Xiao Cheng, Shiqi Hu, Ke Cheng. Microneedle Patch Delivery of PROTACs for Anti-Cancer TherapyACS Nano 2023; 17(12): 11855 doi: 10.1021/acsnano.3c03166
60
Xianghui Zou, Cesar Augusto Santa-Maria, Joseph O'Brien, David Gius, Yueming Zhu. Manganese Superoxide Dismutase Acetylation and Dysregulation, Due to Loss of SIRT3 Activity, Promote a Luminal B-Like Breast Carcinogenic-Permissive PhenotypeAntioxidants & Redox Signaling 2016; 25(6): 326 doi: 10.1089/ars.2016.6641
61
Zi-Rui Liang, Liang-Hu Qu, Li-Ming Ma. Differential impacts of charcoal-stripped fetal bovine serum on c-Myc among distinct subtypes of breast cancer cell linesBiochemical and Biophysical Research Communications 2020; 526(1): 267 doi: 10.1016/j.bbrc.2020.03.049
62
Arpita Roy, Ashutosh Anand, Saksham Garg, Mohd Shahnawaz Khan, Sidharth Bhasin, Muhammad Nadeem Asghar, Talha Bin Emran, Ruchika Garg. Structure-Based In Silico Investigation of Agonists for Proteins Involved in Breast CancerEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/7278731
63
Fatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, Maral Mahboubi Kancha, Milad Ahmadi Najafabadi, Faeze Salem, Setareh Dashti Shokoohi, Sahar Evazi Bakhshi, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani. CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devilFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1018786
64
Shanshan Chen, Lan Bo, Dan Lv, Fei Ma. Bone Safety Profile of Steroidal Aromatase Inhibitor in Comparison to Nonsteroidal Aromatase Inhibitors in Postmenopausal Women with Breast Cancer: A Network Meta-AnalysisBreast Care 2022; 17(4): 391 doi: 10.1159/000523695
65
Md. Rizwanullah, Mohammad Zaki Ahmad, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Shadab Md, Nabil A. Alhakamy, Keerti Jain, Javed Ahmad. Receptor-Mediated Targeted Delivery of Surface-ModifiedNanomedicine in Breast Cancer: Recent Update and ChallengesPharmaceutics 2021; 13(12): 2039 doi: 10.3390/pharmaceutics13122039
66
Linda S. Steelman, Alberto M. Martelli, Lucio Cocco, Massimo Libra, Ferdinando Nicoletti, Stephen L. Abrams, James A. McCubrey. The therapeutic potential of mTOR inhibitors in breast cancerBritish Journal of Clinical Pharmacology 2016; 82(5): 1189 doi: 10.1111/bcp.12958
67
Khairani Sukatendel, M. Fidel Ganis Siregar, Muharam Natadisastra, Iqbal Pahlevi Adiputra Nasution, Syafruddin Ilyas, M. Rhiza Tala, Putri Chairani Eyanoer, Poppy Anjelisa Z. Hasibuan. Benefits of Nigella sativa Extract Protecting Ovary Due to Cisplatin ChemotherapyOpen Access Macedonian Journal of Medical Sciences 2021; 9(A): 680 doi: 10.3889/oamjms.2021.6446
68
Sundee Dees, Rajkumar Ganesan, Sanjaya Singh, Iqbal S. Grewal. Emerging CAR-T Cell Therapy for the Treatment of Triple-Negative Breast CancerMolecular Cancer Therapeutics 2020; 19(12): 2409 doi: 10.1158/1535-7163.MCT-20-0385
69
Hanine Lattouf, Coralie Poulard, Isabelle Treilleux, Nader Hussein, Mona Diab-Assaf, Muriel Le Romancer. LKB1, A New Biomarker in Breast CancerJournal of Cancer Therapy 2016; 7(10): 690 doi: 10.4236/jct.2016.710071
70
Tao Yu, Hai-Ru Yu, Jia-Yi Sun, Zhao Zhao, Shuang Li, Xin-Feng Zhang, Zhi-Xuan Liao, Ming-Ke Cui, Juan Li, Chan Li, Qiang Zhang. miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancerOncotarget 2017; 8(63): 107134 doi: 10.18632/oncotarget.22359
71
Grace S. Hwang, Rutugandha Paranjpe, Carine Opsomer, Kelvin Lu, Uzoamaka Abajue, Susan Abughosh, Hanna Zaghloul, Meghana V. Trivedi. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic InstitutionClinical Breast Cancer 2020; 20(6): 520 doi: 10.1016/j.clbc.2020.06.004
72
Archita Goyal, Gabrielle E. Milner, Ashley Cimino-Mathews, Kala Visvanathan, Antonio C. Wolff, Dipali Sharma, Jennifer Y. Sheng. Weight Gain after Hormone Receptor-Positive Breast CancerCurrent Oncology 2022; 29(6): 4090 doi: 10.3390/curroncol29060326
73
Niraj Neupane, Sawyer Bawek, Sayuri Gurusinghe, Elham Moases Ghaffary, Omid Mirmosayyeb, Sangharsha Thapa, Carla Falkson, Ruth O’Regan, Ajay Dhakal. Oral SERD, a Novel Endocrine Therapy for Estrogen Receptor-Positive Breast CancerCancers 2024; 16(3): 619 doi: 10.3390/cancers16030619
74
M. O. Tserfas, Yu. V. Kuznetsov, V. V. Knyazev, I. S. Levina, I. V. Zavarzin. Key structures in the synthesis of steroid antitumor agents. Methods for upbuilding the 17β-pregnane side chain of 3-methoxy-19-norpregna-1,3,5(10)-trien-20-ones with and without an additional 16α,17α-carbocycleRussian Chemical Bulletin 2022; 71(8): 1806 doi: 10.1007/s11172-022-3593-0
75
Hongjin Li, Susan M. Sereika, Anna L. Marsland, Yvette P. Conley, Catherine M. Bender. Symptom Clusters in Women With Breast Cancer During the First 18 Months of Adjuvant TherapyJournal of Pain and Symptom Management 2020; 59(2): 233 doi: 10.1016/j.jpainsymman.2019.10.002
76
Peng Xing, Huiting Dong, Qun Liu, Fan Yao, Yingying Xu, Bo Chen, Xinyu Zheng, Yunfei Wu, Feng Jin, Jiguang Li. Impact of persistence on survival of patients with breast cancer treated with endocrine therapy in Northeast China: a prospective studyOncotarget 2017; 8(60): 102499 doi: 10.18632/oncotarget.18454
77
Marilena Antunes-Ricardo, Javier Villela-Castrejón, Janet A. Gutiérrez-Uribe, Sergio O. Serna Saldívar. Science and Technology of Fibers in Food SystemsFood Engineering Series 2020; : 241 doi: 10.1007/978-3-030-38654-2_11
78
Muchtaridi Muchtaridi, Muhammmad Jajuli, Muhammad Yusuf. Antagonistic Mechanism of Chalcone Derivatives Against Human Estrogen Alpha of Breast Cancer Using Molecular Dynamic SimulationOriental Journal of Chemistry 2018; 34(6): 2735 doi: 10.13005/ojc/340607
79
Laura A Baker, Holly Holliday, Alexander Swarbrick. ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancerEndocrine-Related Cancer 2016; 23(9): R381 doi: 10.1530/ERC-16-0196
80
Farzin Khosrow‐Khavar, Laurent Azoulay, Jean‐Louis Montastruc, François Montastruc, Christel Renoux. Aromatase inhibitors and the incidence of Parkinson disease: A population‐based cohort studyCancer 2022; 128(12): 2339 doi: 10.1002/cncr.34208
81
Jamie V. Shiah, Daniel E. Johnson, Jennifer R. Grandis. Transcription Factors and CancerThe Cancer Journal 2023; 29(1): 38 doi: 10.1097/PPO.0000000000000639
82
Koch Visser, Oliver Zierau, Dana Macejová, Florian Goerl, Michael Muders, Gustavo B. Baretton, Günter Vollmer, Ann Louw. The phytoestrogenic Cyclopia extract, SM6Met, increases median tumor free survival and reduces tumor mass and volume in chemically induced rat mammary gland carcinogenesisThe Journal of Steroid Biochemistry and Molecular Biology 2016; 163: 129 doi: 10.1016/j.jsbmb.2016.04.019
83
Liming Ma, Zirui Liang, Hui Zhou, Lianghu Qu. Applications of RNA Indexes for Precision Oncology in Breast CancerGenomics, Proteomics & Bioinformatics 2018; 16(2): 108 doi: 10.1016/j.gpb.2018.03.002
84
Wei-Yun Guo, Shang-Ming-Zhu Zeng, Girdhar Singh Deora, Qing-Shan Li, Ban-Feng Ruan. Estrogen Receptor α (ERα)-targeting Compounds and Derivatives: Recent Advances in Structural Modification and BioactivityCurrent Topics in Medicinal Chemistry 2019; 19(15): 1318 doi: 10.2174/1568026619666190619142504
85
Xin Song, Chun-Yu Lin, Xueting Mei, Liyun Wang, Lidan You. Reduction of breast cancer extravasation via vibration activated osteocyte regulationiScience 2022; 25(12): 105500 doi: 10.1016/j.isci.2022.105500
86
ZEINAB KLAAB, AZIZA HASSAN, JAWAHER ALBAQAMI, FAIZAH A. ALMALKI. The effect of natural products combination on MCF-7 cells exceeds tamoxifen therapeutic dose effects in vitroBIOCELL 2023; 47(4): 891 doi: 10.32604/biocell.2023.026556
87
Yeong-Seon Won, Kwon-Il Seo. Lupiwighteone induces caspase-dependent and -independent apoptosis on human breast cancer cells via inhibiting PI3K/Akt/mTOR pathwayFood and Chemical Toxicology 2020; 135: 110863 doi: 10.1016/j.fct.2019.110863
88
Boris Guyot, Veronique Maguer-Satta. Breast Cancer Biology2020;  doi: 10.5772/intechopen.90273
89
Hyung-Jin Lim, Jaehoon Bae, Seon-Gyeong Bak, Nisansala Chandimali, Eun Hyun Park, Sang-Ik Park, Hirofumi Tachibana, Yeong-Seon Won, Seung-Jae Lee. Limocitrin Suppresses Breast Cancer Through Inducing Apoptotic-Cell Death Signaling and Inhibiting the PI3K/AKT/mTOR/S6K Cell Survival SignalingJournal of Medicinal Food 2023; 26(10): 749 doi: 10.1089/jmf.2023.K.0117
90
Fernanda Cardoso da Silva, Douglas Cardoso Brandão, Everton Allan Ferreira, Raoni Pais Siqueira, Helen Soares Valença Ferreira, Ademar Alves Da Silva Filho, Thaise Gonçalves Araújo. Tailoring Potential Natural Compounds for the Treatment of Luminal Breast CancerPharmaceuticals 2023; 16(10): 1466 doi: 10.3390/ph16101466
91
Ren Guanghui, Hao Xiaoyan, Yang Shuyi, Chen Jun, Qiu Guobin. An efficient or methodical review of immunotherapy against breast cancerJournal of Biochemical and Molecular Toxicology 2019; 33(8) doi: 10.1002/jbt.22339
92
Payal Kesharwani, Shiv Kumar Prajapati, Ankit Jain, Nishi Mody, Swapnil Sharma. Polymeric Biomaterials for Healthcare Applications2022; : 211 doi: 10.1016/B978-0-323-85233-3.00006-9
93
Mª Jesús Núñez-Iglesias, Silvia Novio, Carlota García, Mª Elena Pérez-Muñuzuri, María-Carmen Martínez, José-Luis Santiago, Susana Boso, Pilar Gago, Manuel Freire-Garabal. Co-Adjuvant Therapy Efficacy of Catechin and Procyanidin B2 with Docetaxel on Hormone-Related Cancers In VitroInternational Journal of Molecular Sciences 2021; 22(13): 7178 doi: 10.3390/ijms22137178
94
Milad Rouhimoghadam, Anh S. Lu, Aliasger K. Salem, Edward J. Filardo. Therapeutic Perspectives on the Modulation of G-Protein Coupled Estrogen Receptor, GPER, FunctionFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.591217
95
Sheng-Fan Wang, Yuh-Lih Chang, Yen-Dun Tzeng, Chun-Ling Wu, Yuan-Zhong Wang, Ling-Ming Tseng, Shiuan Chen, Hsin-Chen Lee. Mitochondrial stress adaptation promotes resistance to aromatase inhibitor in human breast cancer cells via ROS/calcium up-regulated amphiregulin–estrogen receptor loop signalingCancer Letters 2021; 523: 82 doi: 10.1016/j.canlet.2021.09.043
96
Manouchehr Aghajanzadeh, Hossein Torabi, Behrouz Najafi, Pedram Talebi, Kasra Shirini. Intermammary breast cancer: A rare case of cancer with origin of breast cells in an unusual locationSAGE Open Medical Case Reports 2023; 11: 2050313X2311549 doi: 10.1177/2050313X231154996
97
Kevin Yao, Evelien Schaafsma, Baoyi Zhang, Chao Cheng, Feng Fu. Tumor cell intrinsic and extrinsic features predict prognosis in estrogen receptor positive breast cancerPLOS Computational Biology 2022; 18(3): e1009495 doi: 10.1371/journal.pcbi.1009495
98
Sravanthi Cheeti, Hao Helen Hou, Eric Nelson, Helen Walker, Buyun Chen, Roland Morley, Mary Gates, Luna Musib, Sandhya Girish, Srikumar Sahasranaman, Lichuan Liu. Application of a Novel ‘Make and Test in Parallel’ Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy SubjectsPharmaceutical Research 2018; 35(12) doi: 10.1007/s11095-018-2516-0
99
Dorine de Jong, Elise Desperito, Karine Al Feghali, Laurent Dercle, Romain-David Seban, Jeeban Das, Hong Ma, Abin Sajan, Brian Braumuller, Conor Prendergast, Connie Liou, Aileen Deng, Tina Roa, Randy Yeh, Antoine Girard, Mary Salvatore, Kathleen Capaccione. Advances in PET/CT Imaging for Breast CancerJournal of Clinical Medicine 2023; 12(13): 4537 doi: 10.3390/jcm12134537
100
Wen‐Jing Liu, Gang Zhao, Chen‐Yan Zhang, Chang‐Qing Yang, Xiang‐Bin Zeng, Jin Li, Kun Zhu, Shi‐Qi Zhao, Hui‐Meng Lu, Da‐Chuan Yin, Sheng‐Xiang Lin. Comparison of the roles of estrogens and androgens in breast cancer and prostate cancerJournal of Cellular Biochemistry 2020; 121(4): 2756 doi: 10.1002/jcb.29515
101
Ozge Saatci, Kim-Tuyen Huynh-Dam, Ozgur Sahin. Endocrine resistance in breast cancer: from molecular mechanisms to therapeutic strategiesJournal of Molecular Medicine 2021; 99(12): 1691 doi: 10.1007/s00109-021-02136-5
102
Gi Dae Kim. Ursolic Acid Decreases the Proliferation of MCF-7 Cell-Derived Breast Cancer Stem-Like Cells by Modulating the ERK and PI3K/AKT Signaling PathwaysPreventive Nutrition and Food Science 2021; 26(4): 434 doi: 10.3746/pnf.2021.26.4.434
103
Leseho Swana, Bienvenu Tsakem, Jacqueline V. Tembu, Rémy B. Teponno, Joy T. Folahan, Jarmo-Charles Kalinski, Alexandros Polyzois, Guy Kamatou, Louis P. Sandjo, Jean Christopher Chamcheu, Xavier Siwe-Noundou. The Genus Dacryodes Vahl.: Ethnobotany, Phytochemistry and Biological ActivitiesPharmaceuticals 2023; 16(5): 775 doi: 10.3390/ph16050775
104
Shweta Satpathi, Sagar S Gaurkar, Ashwini Potdukhe, Mayur B Wanjari. Unveiling the Role of Hormonal Imbalance in Breast Cancer Development: A Comprehensive ReviewCureus 2023;  doi: 10.7759/cureus.41737
105
Çağla KAYABAŞI, Sunde YILMAZ SÜSLÜER, Tuğçe BALCI OKCANOĞLU, Besra ÖZMEN YELKEN, Zeynep MUTLU, Cansu ÇALIŞKAN KURT, Bakiye GOKER BAGCA, Çığır BİRAY AVCI, Cumhur GÜNDÜZ. Ponatinib miRNA İfadelerini Düzenleyerek Meme Kanseri Hücrelerini HedeflerUludağ Üniversitesi Tıp Fakültesi Dergisi 2021; 47(3): 365 doi: 10.32708/uutfd.1002443
106
Bharti Mangla, Ozair Alam, Rehan Abdur Rub, Muzaffar Iqbal, Archu Singh, Kuldeep Singh Patel, Kanchan Kohli. Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an oral pharmacokinetic studyJournal of Chromatography B 2020; 1152: 122260 doi: 10.1016/j.jchromb.2020.122260
107
Margaret F. Bedillion, Emily B. Ansell, Gwendolyn A. Thomas. Cancer treatment effects on cognition and depression: The moderating role of physical activityThe Breast 2019; 44: 73 doi: 10.1016/j.breast.2019.01.004
108
Sagir ISMAİL, Adamu UZAİRU, Balarabe SAGAGİ, Muhd Sabiu SULEİMAN. Insilico Molecular Docking and Pharmacokinetic Studies of Selected Phytochemicals With Estrogen and Progesterone Receptors as Anticancer Agent for Breast CancerJournal of the Turkish Chemical Society Section A: Chemistry 2018; 5(3): 1337 doi: 10.18596/jotcsa.449778
109
Meenakshi Sudhakaran, Sagar Sardesai, Andrea I. Doseff. Flavonoids: New Frontier for Immuno-Regulation and Breast Cancer ControlAntioxidants 2019; 8(4): 103 doi: 10.3390/antiox8040103
110
Xi Zhang, Nadia Harbeck, Udo Jeschke, Sophie Doisneau-Sixou. Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancerJournal of Cancer Research and Clinical Oncology 2017; 143(7): 1107 doi: 10.1007/s00432-016-2325-y
111
Sheng-Fan Wang, Yi-Sheng Lin, Wan-Yu Yeh, Yuh-Lih Chang, Chern-En Chiang, Chen-Huan Chen, Ling-Ming Tseng, Hsin-Chen Lee, Chun-Yu Liu, Hao-Min Cheng. The Clinical Benefits of Antiresorptive Agents in Patients with Primary Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review with Pairwise and Network Meta-analysisThe Journal of Clinical Endocrinology & Metabolism 2023; 108(11): e1433 doi: 10.1210/clinem/dgad247
112
Chae Won Ock, Gi Dae Kim. Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling PathwaysMolecules 2021; 26(21): 6714 doi: 10.3390/molecules26216714
113
AbuSamra Nehal, Rashad Mona, Abd ElMoneim Nadia, Shawky Sanaa, Kamel Maher. The prognostic value of vitamin D receptor and its up-stream miR-27b and miR-125a expression in breast cancer patientsGene Reports 2021; 23: 101121 doi: 10.1016/j.genrep.2021.101121
114
Farah J Nassar, Rihab Nasr, Rabih Talhouk. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy predictionPharmacology & Therapeutics 2017; 172: 34 doi: 10.1016/j.pharmthera.2016.11.012
115
Prarthana Chatterjee, Suchetana Gupta, Satarupa Banerjee. Recent Frontiers of Phytochemicals2023; : 261 doi: 10.1016/B978-0-443-19143-5.00004-9
116
Komal L. Jhaveri, Meritxell Bellet, Nicholas C. Turner, Sherene Loi, Aditya Bardia, Valentina Boni, Joohyuk Sohn, Tomas G. Neilan, Rafael Villanueva-Vázquez, Peter Kabos, Laura García-Estévez, Elena López-Miranda, J. Alejandro Pérez-Fidalgo, Jose M. Pérez-García, Jiajie Yu, Jill Fredrickson, Heather M. Moore, Ching-Wei Chang, John W. Bond, Jennifer Eng-Wong, Mary R. Gates, Elgene Lim. Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast CancerClinical Cancer Research 2024; 30(4): 754 doi: 10.1158/1078-0432.CCR-23-1796
117
Gary J. Cheng, Euphemia Y. Leung, Dean C. Singleton. In vitro breast cancer models for studying mechanisms of resistance to endocrine therapyExploration of Targeted Anti-tumor Therapy 2022; : 297 doi: 10.37349/etat.2022.00084
118
Lisa M. Lang, Christian Behr, Marion Ludwig, Jochen Walker, Hans Christian Lange, Frederike Basedow, Christina Justenhoven. Routine practice data of three cancer entities: Comparison among cancer registry and health insurance dataZeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 2023; 177: 65 doi: 10.1016/j.zefq.2023.01.001
119
Mithila Sawant, Audrey Wilson, Dhivya Sridaran, Kiran Mahajan, Christopher J. O’Conor, Ian S. Hagemann, Jingqin Luo, Cody Weimholt, Tiandao Li, Juan Carlos Roa, Akhilesh Pandey, Xinyan Wu, Nupam P. Mahajan. Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitorOncogene 2023; 42(29): 2263 doi: 10.1038/s41388-023-02747-x
120
Manzoor Ahmad Mir, Ulfat Jan. Therapeutic potential of Cell Cycle Kinases in Breast Cancer2023; : 211 doi: 10.1007/978-981-19-8911-7_10
121
Regan Odongo, Asuman Demiroglu-Zergeroglu, Tunahan Çakır. A network-based drug prioritization and combination analysis for the MEK5/ERK5 pathway in breast cancerBioData Mining 2024; 17(1) doi: 10.1186/s13040-024-00357-1
122
Bernice Monchusi, Mandeep Kaur. microRNAs targeting cellular cholesterol: implications for combating anticancer drug resistanceGenes & Cancer 2020; 11(1-2): 20 doi: 10.18632/genesandcancer.202
123
Omolola R. Oyenihi, Annadie Krygsman, Nicolette Verhoog, Dalene de Beer, Michael J. Saayman, Thys M. Mouton, Ann Louw. Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia ExtractFrontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00650
124
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea-Ilies, Rajesh Singh. Targeted Therapy and Mechanisms of Drug Resistance in Breast CancerCancers 2023; 15(4): 1320 doi: 10.3390/cancers15041320
125
Silvia Gobbi, Silvia Martini, Riccardo Rozza, Angelo Spinello, Jessica Caciolla, Angela Rampa, Federica Belluti, Nadia Zaffaroni, Alessandra Magistrato, Alessandra Bisi. Switching from Aromatase Inhibitors to Dual Targeting Flavonoid-Based Compounds for Breast Cancer TreatmentMolecules 2023; 28(7): 3047 doi: 10.3390/molecules28073047
126
MATH: A Deep Learning Approach in QSAR for Estrogen Receptor Alpha InhibitorsMolecules 2023; 28(15): 5843 doi: 10.3390/molecules28155843